Geraldine Venthoye
Chief Tech/Sci/R&D Officer presso VECTURA GROUP
Profilo
Geraldine Venthoye is currently the Co-Managing Director at Vectura GmbH and the Chief Scientific Officer, EVP-Technology & Science at Vectura Group Ltd.
She was previously the Vice President-Pharmaceutical Development at SkyePharma Plc from 2003 to 2014.
She received her doctorate degree from the University of London in 2011.
Posizioni attive di Geraldine Venthoye
| Società | Posizione | Inizio |
|---|---|---|
| VECTURA GROUP | Chief Tech/Sci/R&D Officer | 01/06/2016 |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Chief Executive Officer | - |
Precedenti posizioni note di Geraldine Venthoye
| Società | Posizione | Fine |
|---|---|---|
| SKYEPHARMA PLC | Corporate Officer/Principal | - |
Formazione di Geraldine Venthoye
| University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
- Borsa valori
- Insiders
- Geraldine Venthoye
